FGF21 and lipodystrophy: Given the unmet clinical need for patients with LMNA-induced lipodystrophy, we designed this study to explore the impact of a gene treatment using viral mediated delivery of FGF21 and sTGFBR2 in a preclinical model of LMNA-induced lipodystrophy created in our lab.